{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T16:13:15Z","timestamp":1788883995758,"version":"build-2803163510"},"reference-count":42,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2015,5,5]],"date-time":"2015-05-05T00:00:00Z","timestamp":1430784000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0125075","type":"journal-article","created":{"date-parts":[[2015,5,5]],"date-time":"2015-05-05T17:47:58Z","timestamp":1430848078000},"page":"e0125075","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":20,"title":["DNA Vaccine Encoding the Chimeric Form of Schistosoma mansoni Sm-TSP2 and Sm29 Confers Partial Protection against Challenge Infection"],"prefix":"10.1371","volume":"10","author":[{"given":"Natan Raimundo","family":"Gon\u00e7alves de Assis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suellen","family":"Batistoni de Morais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e1rbara Castro Pimentel","family":"Figueiredo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha Delaqua","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo Augusto","family":"de Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carina","family":"da Silva Pinheiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente de Paulo","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio Costa","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,5,5]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1128\/CMR.00046-07","article-title":"Current status of vaccines for schistosomiasis","volume":"21","author":"DP McManus","year":"2008","journal-title":"Clin Microbiol Rev"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00436-001-0587-y","article-title":"Chemotherapeutic approaches to schistosomes: current knowledge and outlook","volume":"88","author":"A Harder","year":"2002","journal-title":"Parasitol Res"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/S0140-6736(06)69440-3","article-title":"Human schistosomiasis","volume":"368","author":"B Gryseels","year":"2006","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.pt.2005.01.001","article-title":"Vaccine-linked chemotherapy: can schistosomiasis control benefit from an integrated approach?","volume":"21","author":"NR Bergquist","year":"2005","journal-title":"Trends Parasitol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/j.1745-7270.2007.00340.x","article-title":"Characterization of a partially protective B-cell epitope within the 62 kDa antigen of Schistosoma japonicum","volume":"39","author":"L Zhang","year":"2007","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0264-410X(97)00071-6","article-title":"Human schistosomiasis: potential long-term consequences of vaccination programmes","volume":"15","author":"MS Chan","year":"1997","journal-title":"Vaccine"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/nrmicro801","article-title":"Schistosomiasis","volume":"2","author":"L Chitsulo","year":"2004","journal-title":"Nat Rev Microbiol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"633","DOI":"10.4049\/jimmunol.175.2.633","article-title":"DNA vaccines: progress and challenges","volume":"175","author":"JJ Donnelly","year":"2005","journal-title":"J Immunol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"345","DOI":"10.4049\/jimmunol.162.1.345","article-title":"Optimal vaccination against Schistosoma mansoni requires the induction of both B cell- and IFN-gamma-dependent effector mechanisms","volume":"162","author":"D Jankovic","year":"1999","journal-title":"J Immunol"},{"issue":"Suppl 1","key":"ref10","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1590\/S0074-02761998000700013","article-title":"Schistosomiasis vaccine development: progress and prospects","volume":"93","author":"NR Bergquist","year":"1998","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1046\/j.1365-2796.2003.01140.x","article-title":"DNA vaccines: a review","volume":"253","author":"MA Liu","year":"2003","journal-title":"J Intern Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.actatropica.2008.05.023","article-title":"Recent advances in vaccine research against schistosomiasis in Brazil","volume":"108","author":"SC Oliveira","year":"2008","journal-title":"Acta Trop"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"174378","DOI":"10.1155\/2010\/174378","article-title":"DNA vaccines: developing new strategies against cancer","volume":"2010","author":"D Fioretti","year":"2010","journal-title":"J Biomed Biotechnol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1600-065X.2010.00980.x","article-title":"DNA vaccines: an historical perspective and view to the future","volume":"239","author":"MA Liu","year":"2011","journal-title":"Immunol Rev"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1365-3024.2008.01091.x","article-title":"Sm-p80-based DNA vaccine formulation induces potent protective immunity against Schistosoma mansoni","volume":"31","author":"G Ahmad","year":"2009","journal-title":"Parasite Immunol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0264-410X(03)00535-8","article-title":"Protection against Schistosoma mansoni utilizing DNA vaccination with genes encoding Cu\/Zn cytosolic superoxide dismutase, signal peptide-containing superoxide dismutase and glutathione peroxidase enzymes","volume":"22","author":"KA Shalaby","year":"2003","journal-title":"Vaccine"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0264-410X(01)00374-7","article-title":"Immunization with plasmid DNA encoding the integral membrane protein, Sm23, elicits a protective immune response against schistosome infection in mice","volume":"20","author":"AA Da'dara","year":"2001","journal-title":"Vaccine"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/nm1430","article-title":"Tetraspanins on the surface of Schistosoma mansoni are protective antigens against schistosomiasis","volume":"12","author":"MH Tran","year":"2006","journal-title":"Nat Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"e308","DOI":"10.1371\/journal.pntd.0000308","article-title":"Schistosoma mansoni tegument protein Sm29 is able to induce a Th1-type of immune response and protection against parasite infection","volume":"2","author":"FC Cardoso","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"e993","DOI":"10.1371\/journal.pntd.0000993","article-title":"Enzymatic shaving of the tegument surface of live schistosomes for proteomic analysis: a rational approach to select vaccine candidates","volume":"5","author":"W Castro-Borges","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"503068","DOI":"10.1155\/2011\/503068","article-title":"Computational vaccinology: an important strategy to discover new potential S. mansoni vaccine candidates","volume":"2011","author":"CS Pinheiro","year":"2011","journal-title":"J Biomed Biotechnol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1745-7270.2008.00404.x","article-title":"Immunization against Egyptian Schistosoma mansoni infection by multivalent DNA vaccine","volume":"40","author":"MH Romeih","year":"2008","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"e1564","DOI":"10.1371\/journal.pntd.0001564","article-title":"Enhanced protective efficacy of a chimeric form of the schistosomiasis vaccine antigen Sm-TSP-2","volume":"6","author":"MS Pearson","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"7151","DOI":"10.1074\/jbc.M113.531558","article-title":"Solution structure, membrane interactions, and protein binding partners of the tetraspanin Sm-TSP-2, a vaccine antigen from the human blood fluke Schistosoma mansoni","volume":"289","author":"X Jia","year":"2014","journal-title":"J Biol Chem"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1365-2249.2006.03081.x","article-title":"Human antibody responses of patients living in endemic areas for schistosomiasis to the tegumental protein Sm29 identified through genomic studies","volume":"144","author":"FC Cardoso","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"5233","DOI":"10.1093\/nar\/9.20.5233","article-title":"Possible role of flanking nucleotides in recognition of the AUG initiator codon by eukaryotic ribosomes","volume":"9","author":"M Kozak","year":"1981","journal-title":"Nucleic Acids Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"8125","DOI":"10.1093\/nar\/15.20.8125","article-title":"An analysis of 5&apos;-noncoding sequences from 699 vertebrate messenger RNAs","volume":"15","author":"M Kozak","year":"1987","journal-title":"Nucleic Acids Res"},{"key":"ref28","article-title":"A multivalent chimeric vaccine composed of Schistosoma mansoni SmTSP-2 and Sm29 was able to induce protection against infection in mice","author":"CS Pinheiro","year":"2014","journal-title":"Parasite Immunol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0042-6822(62)90290-8","article-title":"Polyoma transformation of hamster cell clones\u2014an investigation of genetic factors affecting cell competence","volume":"16","author":"I Macpherson","year":"1962","journal-title":"Virology"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1073\/pnas.76.9.4350","article-title":"Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications","volume":"76","author":"H Towbin","year":"1979","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1016\/j.micinf.2006.06.008","article-title":"Co-administration of plasmid expressing IL-12 with 14-kDa Schistosoma mansoni fatty acid-binding protein cDNA alters immune response profiles and fails to enhance protection induced by Sm14 DNA vaccine alone","volume":"8","author":"CT Fonseca","year":"2006","journal-title":"Microbes Infect"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.imbio.2005.06.004","article-title":"Immunization with Schistosoma mansoni 22.6 kDa antigen induces partial protection against experimental infection in a recombinant protein form but not as DNA vaccine","volume":"211","author":"LG Pacifico","year":"2006","journal-title":"Immunobiology"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2859-6-1","article-title":"Polymyxin B as inhibitor of LPS contamination of Schistosoma mansoni recombinant proteins in human cytokine analysis","volume":"6","author":"LS Cardoso","year":"2007","journal-title":"Microb Cell Fact"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1046\/j.1365-2567.1996.465550.x","article-title":"Impaired immunity and altered pulmonary responses in mice with a disrupted interferon-gamma receptor gene exposed to the irradiated Schistosoma mansoni vaccine","volume":"87","author":"RA Wilson","year":"1996","journal-title":"Immunology"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.0818-9641.2004.01272.x","article-title":"Vaccine adjuvants: current state and future trends","volume":"82","author":"N Petrovsky","year":"2004","journal-title":"Immunol Cell Biol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/j.vaccine.2008.02.033","article-title":"The relative immunogenicity of DNA vaccines delivered by the intramuscular needle injection, electroporation and gene gun methods","volume":"26","author":"S Wang","year":"2008","journal-title":"Vaccine"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"e597","DOI":"10.1371\/journal.pntd.0000597","article-title":"Schistosoma mansoni Stomatin like protein-2 is located in the tegument and induces partial protection against challenge infection","volume":"4","author":"LP Farias","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1365-3024.2009.01181.x","article-title":"Sm-p80-based DNA vaccine made in a human use approved vector VR1020 protects against challenge infection with Schistosoma mansoni in mouse","volume":"32","author":"W Zhang","year":"2010","journal-title":"Parasite Immunol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.imlet.2011.09.003","article-title":"Immunization with rP22 induces protective immunity against Schistosoma mansoni: effects on granuloma down-modulation and cytokine production","volume":"141","author":"CM Rezende","year":"2011","journal-title":"Immunol Lett"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nri843","article-title":"The immunobiology of schistosomiasis","volume":"2","author":"EJ Pearce","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"6533","DOI":"10.4049\/jimmunol.167.11.6533","article-title":"Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1\/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism","volume":"167","author":"M Hesse","year":"2001","journal-title":"J Immunol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/0952-7915(95)80095-6","article-title":"Cytokine regulation of granuloma formation in schistosomiasis","volume":"7","author":"TA Wynn","year":"1995","journal-title":"Curr Opin Immunol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0125075","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T03:35:18Z","timestamp":1691638518000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0125075"}},"subtitle":[],"editor":[{"given":"Mauricio Martins","family":"Rodrigues","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,5,5]]},"references-count":42,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2015,5,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0125075","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,5]]}}}